Improving survival among men with oligorecurrent prostate cancer?

A newly published article in the Journal of Clinical Oncology reports data from a small, randomized, multicenter, Phase II clinical trial comparing active monitoring to treatment of men with recurrent, asymptomatic, oligometastatic prostate cancer. … READ MORE …

Howard’s got the vitamins to prove … something!

In his latest blog post on the MedPage Today web site (which seems to to be spreading way beyond his prostate cancer — successfully managed with active surveillance to date), Howard Wolinsky talks about what it’s costing to keep himself in vitamins (mostly not for his prostate cancer)! … READ MORE …

Many low-risk patients are not hearing about active surveillance as an appropriate management option

Current guidelines from the American Urological Association (AUA), the American Society for Radiation Oncology (ASTRO), and the National Comprehensive Cancer Network (NCCN) all clearly state that, for men diagnosed with low-risk prostate cancer, active surveillance is an appropriate form of first-line management. However, … … READ MORE …

For patients on or considering active surveillance

Prostate Cancer International wishes to announce the development and official opening of its online Active Surveillance Virtual Support Group. … READ MORE …

The MEAL study — an update

Back in 2011, what is now the Alliance for Clinical Trials in Oncology (ACTO) but was then CALGB (Cancer and Leukemia Group B) initiated the Men’s Eating and Living (MEAL) study. This trial is, we hope, going to give us some real answers to a very important question: does diet affect risk for the progression of prostate cancer in men on active surveillance? … READ MORE …

An update from Howard Wolinsky — on active surveillance + type 2 diabetes (and the power of diet)

So regular readers will be aware of several articles by Howard Wolinsky on his experiences as a man monitoring low-risk prostate cancer on active surveillance since 2010. Apparently this was insufficiently challenging. In June he was diagnosed with type 2 diabetes (T2B) as well. … READ MORE …

5-year data from another large series of men on active surveillance

A new article in the Scandinavian Journal of Urology has provided 5-year outcomes data from a large, prospective, single-center study of men in Denmark initially managed on active surveillance. … READ MORE …